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Early & Periodic Screening, Diagnosis & Treatment
(continues on page 2)
Early motor development begins 
in “fetushood.” The perception of 
fetal movement occurs as early 
as 16-weeks gestation, beginning 
as small flutters and advancing 
to strong kicks and jabs. Fetal 
movement counts have long been 
recommended as a means of 
monitoring the health of the fetus. 
Decreased fetal movement can be 
cause for concern and may stem 
from environmental factors such 
as infection, decreased placental 
blood flow, poor oxygenation, 
medication, and toxins. In some 
cases it can indicate development 
of problems within the nervous 
system (brain malformations, 
encephalopathy, and neural 
tube defects) or musculoskeletal 
system (myopathy, neuromuscular 
disorder, and arthrogryposis). 
Neurodevelopmental assessment 
begins shortly after birth with 
assessment of tone, movement, 
and reflexes. More mature babies 
will generally have more muscle 
tone than premature or immature 
Early Motor Development
By Andrea Reasoner, M.D. University of Iowa Children’s Hospital
about transitioning between 
positions is also important.  
For example, a child may be able 
to sit without support, yet not 
be able to get from a horizontal 
position to a sitting position on 
his own. Likewise, a child may 
be able to stand along furniture 
when placed there, but not be able 
to pull to a stand. Assessing the 
necessary transitioning abilities is 
important to avoid overestimating 
motor development based only 
on ability to maintain a position. 
While there is a broad age range 
of normal development, if a 
child is consistently achieving 
all milestones at the end of 
the range, he is likely delayed. 
Referral for physical therapy 
services and further evaluation 
with a pediatric neurologist and/
or a developmental behavioral 
pediatrician is warranted. Watchful 
waiting may lead to additional 
parental anxiety and a greater 
lag in the child’s development. 
babies. Forward progress in 
neuromotor development should 
be evident at each well check.  
Up until two years of age, develop-
ment of a premature baby should 
be assessed in terms of the 
adjusted age (chronological age 
minus weeks of prematurity).
The typical gross motor milestones 
of sitting without support, crawling, 
and walking without assistance 
are commonly used to monitor 
development; however thinking 
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Early intervention through the 
AEA usually requires a 25 percent 
delay; however there may be other 
indications for private PT or OT 
services, such as muscle weakness 
or toe walking. Private services 
may be used in addition to early 
intervention/Early Access services  
if more intensive therapy is  
deemed appropriate.
Knowing when to refer infants 
for physical therapy services can 
be tricky in subtle cases unless 
periodic developmental screening 
is being done. When infants are 
behind on milestones, a short 
course of physical therapy may  
be all that is needed to move  
them along. Timely mobility 
is important for exploring the 
environment, which promotes 
language and cognitive develop-
ment. Motor delay can also be 
part of a more global delay in 
developmental disorders, such 
as autism, which may ultimately 
involve intellectual disability.  
In those situations, early inter-
vention can focus on acquisition of 
milestones in a coordinated e!ort, 
focusing on those skills that will 
be of most benefit in the child’s 
developmental timeline.
According to the 2006 WHO  
Motor Development Study,  
99 percent of children were  
able to sit without support by  
9.2 months, stand with assistance  
by 11.4 months, crawl on hands 
and knees by 13.5 months, walk 
with assistance by 13.7 months, 
stand alone by 16.9 months,  
and walk alone by 17.6 months.  
In this study, 4.3 percent of  
children did not crawl on  
hands and knees.1 
 The National Task Force for 
Early Identification of Childhood 
Neuromuscular Disorders has 
provided red flag ages for when 
to refer to early intervention and 
when to check creatinine kinase 
level (CK) and refer to a neurologist. 
These ages are generally some-
where around the 75 percent and 
90 percent norms for motor skill 
acquisition using the Denver II 
or the WHO Motor Development 
Study. The figure on page three 
incorporates these guidelines  
and the norms.2
Early Motor Development
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to distal. Arms become supportive 
for rolling over and for sitting 
before the smaller muscles of the 
hands develop for picking up  
small objects, scribbling, or using 
spoons.3 Fine motor development 
also depends on gross motor, 
cognitive, and visual development. 
According to the Denver II, most 
babies (90 percent) are able to 
grasp a rattle by four months, pick 
up a small object with a pincer 
(thumb-finger) grasp by 10.5 
months, and scribble by 16.5 
months. Most children can use a 
spoon for eating at 20 months.
Standardized developmental 
screening is helpful for assessing 
whether a child meets criteria 
for further assessment or early 
intervention. Many pediatric 
o"ces use the Ages and Stages 
Questionnaire-3rd edition (ASQ-3) 
for early identification of delays. 
Considered to be the gold standard 
for developmental screening, it is 
used in many di!erent settings, 
including Child Find and Early 
Head Start. Infants and toddlers 
who qualify for early intervention 
services may receive those without 
cost to them under Part C of 
the Individuals with Disabilities 
Education Act (IDEA). ASQ-3 also 
identifies three groups of children; 
those who need to be referred  
for early intervention, those who  
need monitoring along with  
home intervention by parents,  
and those who are developing 
typically so parents can be 
reassured. Administering the ASQ-
3 provides an additional benefit 
of increasing child development 
awareness in parents, health care 
providers, childcare sta!, and those 
in medical or caregiver training.4
There is considerable variation  
in red flags for referral according  
to various studies. In general, if a 
child lacks steady head control 
while sitting at four months, is 
unable to sit at nine months, or is 
unable to walk independently at  
18 months, a medical evaluation 
and more thorough developmental 
evaluation are recommended. 
These red flags are listed in the 
2010 Pediatrics in Review article, 
“Developmental Milestones:  
Motor Development.”  The article 
further describes the progression 
and refinement of neurodevelop-
ment, which generally proceeds 
from head to toe and from proximal 
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Although timing of motor 
milestones is important, other 
factors such as muscle tone, 
quality of movement, and 
reflexes (primitive, postural, and 
deep tendon) are necessary 
features when looking at motor 
development. Premature babies 
may have some tone variation 
during the first year of life, 
especially lower tone that can 
eventually normalize. However 
two conditions, the first being 
persistent hypertonia, and the 
second being hypotonia which 
evolves into hypertonia, are 
concerning for cerebral palsy. 
Hyperreflexia suggests a central 
nervous system process such  
FIGURE 1: Developmental Milestones
(continues on page 4)
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as brain injury or cerebral palsy  
where hyporeflexia is more 
concerning for a peripheral  
nervous system or muscular 
disorder. Absent deep tendon 
reflexes are very concerning for 
spinal muscular atrophy in a 
hypotonic infant.
Babies who develop an early  
hand preference, drag one leg,  
or neglect to use one side of  
the body are showing atypical 
motor patterns concerning for 
a unilateral brain injury such as 
a stroke. Wobbly movements, 
unusual posturing of limbs or  
body, excessive tremor, and 
persistent wide-based gait may 
be signs of an emerging move-
ment disorder. If a child plateaus 
in development or regresses 
or loses motor skills that were 
previously acquired, he should 
be promptly referred for further 
evaluation due to concern for a 
progressive neurological, muscular, 
or metabolic disorder, which  
may be potentially treatable.
Children with neurological con-
ditions associated with gross and/
or fine motor delay may have 
additional motor impairments 
involving the mouth and face, 
such as trouble articulating sounds 
and forming words (dysarthria), 




the skill by 
this age
Age to refer 
for early 
intervention 
therapy (if skill 
not achieved)
Age to obtain  
CK and refer  
to specialist  
for further  
evaluation 








Pulls to sit 
without 
head lag
4 months 4 months  5 months 6.5 months Denver II
Sits without 
support





9.5 months 9 months 10 months Denver II
Walks alone/ 
Rise to stand 
without  
support
13.1 months 15 months 18 months  
(or if regression)
14.4 months WHO Motor 
Development 
Study
Runs 18.5 months 20 months 24 months  
(or if regression)
21 months Denver II
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or drooling (sialorrhea). There may 
be associated visual findings of 
strabismus, nystagmus, or cortical 
visual impairment. It is important  
to keep in mind the impact of 
vision on motor development;  
poor vision can lower confidence 
and dampen the desire to explore 
the environment and handle  
new experiences.
Head circumference, especially  
in comparison to stature, is an 
important part of the neuro-
developmental assessment, as both 
microcephaly and macrocephaly 
can be seen with delayed or 
atypical motor development and 
reflect a static or progressive 
disease process. Hypothyroidism 
should be considered in the 
context of hypotonia, especially  
if there is macrocephaly or  
delayed closure of the anterior 
fontanel. Dysmorphic features 
would raise the likelihood of a 
genetic condition.
Children with low muscle tone  
or muscle weakness can be 
screened easily for neuromuscular 
conditions and muscular dystrophy 
by obtaining a creatinine kinase 
(CK). Signs of muscular dystrophy 
can be present at birth, but may 
also emerge around two years of 
age or older, beginning as proximal 
muscle weakness, especially in 
the lower limbs, then gradually 
involving the arms and more 
distal extremities. Observation 
of a child moving from sitting to 
standing can alert you to proximal 
weakness if the child uses the 
legs as a support to push o! 
with the arms, the classic Gowers 
maneuver. Walking up steps and 
jumping may also be di"cult with 
proximal weakness. When lifting 
a young child with proximal arm 
weakness, you may feel like the 
child is going to slip through your 
hands, the classic “slip-through 
e!ect.” Children who fatigue easily 
with activity also may need to be 
screened. Lordosis, waddling gait, 
and calf hypertrophy are other 
signs of muscular dystrophy in 
children with muscle weakness 
and developmental delay. To 
distinguish the waddling gait 
from the wide-based gait, look for 
exaggerated drops and elevations 
in the pelvis with side-to-side 
swaying. A normal CK (24-180 
U/L) does not totally exclude a 
neuromuscular disease, so clinical 
suspicion would prevail when 
deciding upon referral, especially  
if there are other indicators. 
Presence of tongue fasciculations 
and loss of motor skills would be 
very concerning indicators and 
cause for referral regardless of CK 
level. A mildly elevated CK (180-
3,000 U/L) should be retested 
after two to three weeks. If still 
abnormal, the child should be 
referred to pediatric neurology.  
If the CK is grossly elevated (3,000-
50,000 U/L), the test should be 
repeated in one week and referral 
made to a pediatric neurologist  
if it is still elevated or there are 
other concerns. Levels higher than  
50,000 indicate rhabdomyolysis 
which requires hospitalization.5 
Children with muscle weakness 
should be evaluated for risk of 
malignant hyperthermia prior to 
procedures requiring anesthesia. 
Complete clinical assessment is 
crucial and should factor in to  
any referral decisions.
As a final comment, validation 
of parent or caregiver concerns 
about motor development is an 
important part of the develop-
mental evaluation. Using 
standardized tools such as the 
ASQ-3 can provide valuable 
information on which to base 
referral decisions for those children 
with mild or isolated delays. If a 
decision is made to watch and 
wait, the waiting time should not 
extend beyond the time when 90 
percent of children are performing 
at that skill level. Developmental 
intervention is most successful 
when initiated soon after early 
identification of delays.
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Adolescent 
Screening for Depression
EPSDT recommends that all adolescents ages 11-21 are screened for 
depression using the PHQ-2. If it is abnormal, then a PHQ-9 should be completed. 
Sources:
1.  Thibault JM, Steiner RW. E!cient identification of adults with depression and dementia.  Am Fam Physician. 2004;70:1101–1110
2. Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a  two-item depression screener. Med Care. 2003;41:1284–1292 
3. Information from Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2:  validity of a two-item depression screener. Med Care. 2003;41:1284–1292
Little interest or pleasure in doing things.
 0 = Not at all
 1 = Several days
 2 = More than half the days  
 3 = Nearly every day
Patient Health Questionnaire-2 
Instructions for Use
The PHQ-2 includes the first 2 items of the PHQ-9. The stem question is, “Over the past 2 weeks, how often 
have you been bothered by any of the following problems?” The 2 items are “Little interest or pleasure in doing 
things” and “Feeling down, depressed, or hopeless.” For each item, the response options are “Not at all,” “Several 
days,” “More than half the days,” and “Nearly every day,” scored as 0, 1, 2, and 3, respectively. Thus, the PHQ-2 
score can range from 0 to 6.2 A score of 3 points or more on this version of the PHQ-2 has a sensitivity of 83 
percent and a specificity of 92 percent for major depressive episode.1
Screening with the PHQ-2 is only a first step. Patients who screen positive should be further evaluated with 
the PHQ-9, other diagnostic instruments, or direct interview to determine whether they meet criteria for a 
depressive disorder.2
Score interpretation:                                                                                                                                                                                                             
  Probability of major  Probability of any 
 PHQ-2 score depressive disorder (%) depressive disorder (%)
                                                                                                                                                                                                                
 1 15.4 36.9
 2 21.1 48.3
 3 38.4 75.0
 4 45.5 81.2
 5 56.4 84.6
 6 78.6 92.9
Over the past 2 weeks, how often have you been bothered by any of the following problems? 
Feeling down, depressed, or hopeless.
 0 = Not at all
 1 = Several days
 2 = More than half the days  
 3 = Nearly every day
Total point score:                         
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Adolescent Screening for Depression, continued
PHQ-9 Quick Depression Assessment
Instructions for Use 
for doctor or healthcare professional use only
For initial diagnosis:
1. Patient completes PHQ-9 Quick Depression Assessment.
2. If there are at least 4 s in the two right columns (including Questions #1 and #2), 
 consider a depressive disorder. Add score to determine severity.
3. Consider Major Depressive Disorder 
 • if there are at least 5 s in the two right columns (one of which corresponds to Question #1 or #2).
 Consider Other Depressive Disorder 
 • if there are 2-4  s in the two right columns (one of which corresponds to Question #1 or #2).
Note: Since the questionnaire relies on patient self-report, all responses should be verified by the clinician, and a definitive diagnosis is made on 
clinical grounds taking into account how well the patient understood the questionnaire, as well as other relevant information from the patient.
Diagnoses of Major Depressive Disorder or Other Depressive Disorder also require impairment of social, occupational, or other important areas 
of functioning (Question #10) and ruling out normal bereavement, a history of a Manic Episode (Bipolar Disorder), and a physical disorder, 
medication, or other drug as the biological cause of the depressive symptoms.
To monitor severity over time for newly diagnosed patients  
or patients in current treatment for depression:
1. Patients may complete questionnaires at baseline and at regular intervals (eg, every 2 weeks) at home  
 and bring them in at their next appointment for scoring or they may complete the questionnaire  
 during each scheduled appointment.
2. Add up  s by column. For every :  Several days = 1      More than half the days = 2       Nearly every day = 3
3. Add together column scores to get a TOTAL score.
4. Refer to the accompanying PHQ-9 Scoring Box to interpret the TOTAL score.
5. Results may be included in patient files to assist you in setting up a treatment goal, determining  
 degree of response, as well as guiding treatment intervention.
PHQ9 Copyright © Pfizer Inc. All rights reserved. Reproduced with permission. PRIME-MD ® is a trademark of Pfizer Inc.
PHQ-9 SCORING CARD FOR SEVERITY DETERMINATION  
(for healthcare professional use only)
Scoring—add up all checked boxes on PHQ-9
For every :  Not at all = 0; Several days = 1;
More than half the days = 2; Nearly every day = 3
 INTERPRETATION OF TOTAL SCORE




 15-19 Moderately severe
 20-27 Severe






Adolescent Screening for Depression, continued
Developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke and colleagues, with an educational grant from P!zer, Inc. 
Copyright © 2005 Pfizer Inc.  All rights reserved.  Reproduced with permission. 
I con!rm this information is accurate.                                     Patient’s/Subjects’s initials:                                            Date:                                  
If you checked o" any problems, how di#cult have 
those problems made it for you to do your work, take 
care of things at home, or get along with other people?
 TNot di"cult at all 
 TSomewhat di"cult 
 TVery di"cult 
 TExtremely di"cult
Over the last 2 weeks, how often have you been bothered 











1. Little interest or pleasure in doing things 0 1 2 3
2. Feeling down, depressed, or hopeless 0 1 2 3
3. Trouble falling or staying asleep, or sleeping too much 0 1 2 3
4. Feeling tired or having little energy 0 1 2 3
5. Poor appetite or overeating 0 1 2 3
6. Feeling bad about yourself — or that you are a failure or
have let yourself or your family down
0 1 2 3
7. Trouble concentrating on things, such as reading the 
newspaper or watching television
0 1 2 3
8. Moving or speaking so slowly that other people could have 
noticed? Or the opposite — being so fidgety or restless that 
you have been moving around a lot more than usual
0 1 2 3
9. Thoughts that you would be better o! dead or of hurting 
yourself in some way
0 1 2 3
Scoring for use by study personnel only
       0        +                 +                 +              
 = Total Score                        
Patient Health Questionnaire-9
THIS SECTION  FOR USE BY STUDY PERSONNEL ONLY.
Were data collected?  No T(Provide reason in comments)
If Yes, data collected on visit date Tor specify date:                             
Comments:
Only the patient (subject) should enter information into this questionnaire.
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The  EPSDT Care for Kids Newsletter  is published 
three times a year, in print and online, as a joint 
e!ort of the Iowa Prevention of Disabilities Policy 
Council, the Iowa Department of Human Services, 
the Iowa Department of Public Health, and the 
Center for Disabilities and Development, which is 
nationally designated as Iowa’s University Center for 
Excellence on Disabilities. The goal of this newsletter 
is to inform Iowa health care professionals about 
the EPSDT Care for Kids program, to encourage 
them to make use of this important resource, and 
to provide them with information about a wide 
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100 Hawkins Drive
Iowa City, IA 52242-1011
If you have questions about billing related to EPSDT Care for Kids services, please call Provider 
Services:  1- 800-338-7909. If you have questions about clinical issues and EPSDT Care for Kids 
services, please call 1 - 800-383-3826. Please note:  Due to budget restraints, the EPSDT Care for 
Kids Newsletter is sent to o"ces and organizations, rather than to individuals. The newsletter is 
also available on line at www.iowaepsdt.org.  Readers are welcome to photocopy or download 
material from the newsletter to share with others.  If you wish to reproduce material from the 
newsletter in another publication, whether print or electronic, please obtain permission prior to 
publication by contacting the editor. Please include the following acknowledgment with reprinted 
material: Reprinted by permission of the Iowa EPSDT Care for Kids Newsletter.
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